In the last years investigation of resolution phase of inflammatory process take increasing importance. In was shown, that resolution phase is active process, which is regulated by many endogenous factors. Disturbance of the resolution phase is a one of principal reasons of chronic inflammatory diseases. Basing on these investigations new strategy of inflammatory diseases treatment was developed. The strategy is based on pharmacological regulation of resolution inflammatory phase.

Based on this strategy we have proposed new method for screening and development of anti-inflammatory drugs of new generation. At our site you can found short article about new strategy, developed in our group.

Read more...